|
| Study type | Year | Condition | # of pat. | Plasma source/certification | Outcome with plasma treatment | Allocation | Ref. |
|
| Case series | 2015 | Infected wounds | 11 | kINPen MED (certified) | Complete healing of the wounds | N/A | [242] |
| Case series | 2016 | Advanced head and neck cancer | 21 | kINPen MED (certified) | No enhanced tumor growth and more apoptotic cell kill | N/A | [121] |
| Case report | 2016 | Percutaneous driveline infection | 1 | kINPen MED (certified) | Completed regression of local infection | N/A | [243] |
| Case series | 2016 | Nonhealing wounds | 4 | kINPen MED (certified) | Completed wound repair | N/A | [202] |
| Case series | 2017 | Nonhealing wounds | 6 | PlasmaDerm (certified) | Completed remission | N/A | [201] |
| Case series | 2017 | Actinic keratosis | 5 | FE-DBD (not certified) | 17 lesions: 9 showed full regression, 3 significantly improved, 5 showed no change | N/A | [203] |
| Case series | 2018 | Warts | 2 | FE-DBD (not certified) | Patient 1: wart cleared; patient 2: wart improved but not cleared | N/A | [205] |
| Case series | 2018 | Therapy-resistant corneal infections | 4 | kINPen MED (certified) | Significantly elimination of pathogens | N/A | [244] |
| Case series | 2018 | Actinic keratosis | 7 | SteriPlas (certified) | Overall decline of actinic keratosis characteristics | N/A | [204] |
| Case series | 2020 | Warts | 5 | FE-DBD (not certified) | 4 warts cleared, 1 did not change | N/A | [206] |
| Clinical trial | 2011-2012 | Chronic venous leg ulcers | 14 | PlasmaDerm (certified) | Significantly improved ulcer size-reduction | Random | [245] |
| Clinical trial | 2016-2020 | Actinic keratosis, acne, verruca plana | 100 | Plasma to treat skin lesions and acne | Successful cure in most of them | Nonrandom | [210] |
| Clinical trial | 2017-2020 | Facial wrinkles, rhytides | 55 | J-Plasma He-jet (FDA approved) | Significant improvement, no serious adverse events | N/A | [246] |
| Clinical trial | 2017-2020 | Cervical intraepithelial neoplasia | 170 | Plasma treatment | Pathological remission and HPV reduction | Nonrandom | [208] |
| Clinical trial | 2017-2018 | Intact skin, experimental contaminant added to patient skin | 25 | Plasma | Safety, efficacy, and efficiency of plasma for burn wound treatment | Nonrandom | [247] |
| Clinical trial | 2017-2019 | Onychomycosis of toenail | 5 | Plasma treatment | Mycological cure, evident nail growth | N/A | [248] |
| Clinical trial | 2019 | Wound healing | 100 | Cold argon Plasma | Ongoing, no results have been yet reported | Random | [249] |
| Clinical trial | 2020 | Androgenetic alopecia | 40 | Plasma-treated aqueous-alcohol solution | Ongoing, no results have been yet reported | N/A | [211] |
|
